Infinium Global Research has undertaken a new report on Global Injectable Drug Delivery Market: Trends Analysis and Forecast 2021. The report presents analysis global as well as regional markets of Injectable Drug Delivery over the period of 2015 to 2021 Moreover, the IGR-Growth Matrix given in the report provides key focus areas and investment areas the market players can focus on. The market size is presented in terms of value for the historic year 2015 and estimated for forecast period of 2016 to 2021.
Get 15% discount for early purchase of “Global Injectable Drug Delivery Market by region (North America, Europe, Asia Pacific, and RoW)” report on
Injectable drug delivery is defined as administration of a drug or drugs directly into patient’s blood circulation through a delivery device. It is considered as the most common and effective route of administration of most therapeutic agents to achieve the desired quick response. The injectable route of drug administration is expected to continue to be an important delivery system. This has been attributed to reasons that injectable drug delivery system allows administration of drugs with poor oral bioavailability, delivery of the drug at the site of action, targeted drug delivery system.
Reduction in the number of injection is achieved by various technologies such as controlled release, targeted delivery and needle free delivery thus overcoming the problems associated with conventional injectable drug delivery. This has also helped in improving quality of therapy. Injectable drug delivery has also proved beneficial in many cases such as unconsciousness, emergency conditions and nausea, due to rapid onset of action. The basic requirement for injectable drug delivery is that it should be pyrogen free, sterile and isotonic.
The global injectable drug delivery market is dominated by North
America and is followed by Europe. However the North American region
lags behind European injectable market in self-injection devices due to
low penetration rate of pen injectors in the U.S. The emerging Asian and
Latin American countries collectively represent the fastest growing
market for injectables due to the increase in incidences of cancer and
diabetes in patients and also their compliance to novel technologies.
Furthermore, the drug and device manufacturers are focusing on major
emerging injectables market of Asia and Latin America due to less
stringent regulations for acquiring approvals on devices and less
competition. Moreover the report provides deep insights on demand forecasts,
market trends and micro and macro indicators. In addition, this report
provides insights on the factors that are driving and restraining the
demand globally as well as regionally. Moreover, Infinium Global
Research- Growth Matrix (IGR- Growth Matrix) given in the report brings
an insight on the investment areas that existing or new market players
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of Injectable Drug Delivery. Moreover, the study highlights current market trends and provides forecast from 2016 to 2021. We also have highlighted future trends in the Injectable Drug Delivery that will impact the demand during the forecast period.
The Infinium Global Research- Growth Matrix (IGR- Growth Matrix) provided in this report highlights key investing markets in the world. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors to understand the present and future trends in this market and formulate their strategies accordingly.
The companies covered in the report include Becton, Dickinson and Company (U.S.), Baxter International Inc. (U.S.), Gerresheimer AG (Germany), Pfizer, Inc. (U.S.), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel), and Eli Lilly and Company (U.S.).
Reasons to buy this report
- Comprehensive analysis of global as well as regional markets of Injectable Drug Delivery
- Complete coverage of all the type, therapeutic application, usage pattern, mode of administration, and end user segments to analyze the trends, developments, and forecast of market size up to 2021.
- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
- Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.
Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.